PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
09-Feb-2024 Lineage Cell Therapeutics Announces Closing of $14.0 Million Registered Direct Offering Businesswire
09-Feb-2024 Women's Health and Beauty Supplements Global Industry Research Report 2024: Popularity of CBD and Rising Interest in Collagen Supplementation Amplifying Growth - Long-term Forecasts to 2028 and 2033 - ResearchAndMarkets.com Businesswire
09-Feb-2024 Catalent, Inc. Reports Second Quarter Fiscal 2024 Results Businesswire
09-Feb-2024 Precision BioSciences to Effect a Reverse Stock Split Businesswire
09-Feb-2024 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
09-Feb-2024 TME Pharma Announces the End of the Convertible Debt Program With the Successful €1.48 Million Financing Intended for Buyback of All Outstanding Convertible Debt Businesswire
09-Feb-2024 Sensorion Announces a €50.5 Million Financing With Participation From New and Existing US and European Healthcare Specialist Investors Businesswire
09-Feb-2024 Baron & Budd: Court Approves Massive $1.1 Billion Settlement With DuPont to Resolve “Forever Chemicals” Contamination Suits Businesswire
09-Feb-2024 Takeda Intends to Rapidly Initiate the First Global Phase 3 Trials of TAK-861, an Oral Orexin Agonist, in Narcolepsy Type 1 in First Half of Fiscal Year 2024 Businesswire
09-Feb-2024 ACI: NYC Bill to Restrict Safe Detergent Chemistry is Unnecessary, Would Disrupt Sustainable Innovation Businesswire
09-Feb-2024 Sensient Technologies Corporation Reports Results for the Quarter Ended December 31, 2023 Businesswire
09-Feb-2024 Aptar Reports Fourth Quarter and Annual 2023 Results Businesswire
09-Feb-2024 AdaptHealth Corp. Announces Fourth Quarter and Full Year 2023 Earnings Release Date and Conference Call Businesswire
09-Feb-2024 Prothena to Report Fourth Quarter and Full Year 2023 Financial Results on February 15, 2024 Businesswire
09-Feb-2024 Celyad Oncology Announces Intention to Terminate SEC Reporting Obligations Businesswire
08-Feb-2024 Viz.ai Receives FDA 510(k) Clearance for Artificial Intelligence Algorithm for the Quantification of Intracerebral Hemorrhage Businesswire
08-Feb-2024 MaaT Pharma: Monthly Information Regarding the Total Number of Voting Rights and Shares Comprising the Share Capital Businesswire
08-Feb-2024 Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of January 31st, 2024 Businesswire
08-Feb-2024 X-FAB Fourth Quarter and Full Year 2023 Results Businesswire
08-Feb-2024 Samsung Launches New Women’s Health Online Resource at SMFM 2024 Pregnancy Meeting Businesswire